Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors

Clinical trial NCT00730470 · COMPLETED

Trial details

NCT number: NCT00730470
Sponsor: U3 Pharma GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2008-08-01
Primary completion: 2010-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.